Brain metastases in breast cancer Journal Article


Authors: Sim, H. W.; Morris, P. G.; Patil, S.; Khasraw, M.
Article Title: Brain metastases in breast cancer
Abstract: Despite therapeutic advances, the development of breast cancer brain metastases (BCBM) is still the harbinger of a dismal prognosis. Patient outcomes vary depending on factors, including tumor phenotype, extent of disease within and outside the brain, as well as patient performance status. Treatment includes surgery, radiation therapy and systemic therapy determined by patient and tumor characteristics. Despite these approaches, novel treatments are needed and there is growing interest in systemic therapies. However, the efficacy of pharmacologic agents is hampered by poor penetration of drugs across the blood-brain barrier. Therefore, there is a pressing need for a greater understanding of the natural history of BCBM to guide the development of further therapies. This review analyzes prognosis and treatment of BCBM by tumor phenotype and discusses ongoing research into new therapies. © Informa UK, Ltd.
Keywords: systemic therapy; breast cancer; brain metastases; treatment of breast cancer brain metastases
Journal Title: Expert Review of Anticancer Therapy
Volume: 14
Issue: 2
ISSN: 1473-7140
Publisher: Taylor & Francis Group  
Date Published: 2014-02-01
Start Page: 173
End Page: 183
Language: English
DOI: 10.1586/14737140.2014.863468
PROVIDER: scopus
PUBMED: 24308683
DOI/URL:
Notes: Export Date: 3 March 2014 -- CODEN: ERATB -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sujata Patil
    511 Patil
  2. Patrick Glyn Morris
    116 Morris